Grants and Contributions:
Title:
Automation of Novel Allograft Processing/Packaging Unit for DermGEN™
Agreement Number:
918410
Agreement Value:
$50,000.00
Agreement Date:
Jan 3, 2019 - Apr 19, 2019
Description:
DermGEN™ has been developed as a novel decellularized allograft for the wound care market and is poised to commence commercial sales. DeCell Technologies proposal is to automate the decellularization process, using a closed system, dramatically reducing risks of contamination. Full automation of such a system has not been achieved by competing products, and would significantly differentiate DeCell Technologies platform from the competition as well as providing a significant cost advantage.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Upper Tantallon, Nova Scotia, CA B3Z 0G2
Reference Number:
172-2018-2019-Q4-918410
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819980301
Recipient Type:
For-profit organization
Recipient's Legal Name:
DeCell Technologies Incorporated
Federal Riding Name:
South Shore--St. Margarets
Federal Riding Number:
12009
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710